|
However, severe reactions, such as hypotension requiring treatment, dyspnoea requiring bronchodilators, angioedema or generalised urticaria require immediate discontinuation of taxol and appropriate emergency therapy.
39. Fink, D., Zheng, H., Nebel, S., Norris, P. S., Aebi, S., Lin, T-P., Nehme, A., Christen, R. D., Haas, M., MacLeod, C. L., and Howell, S. B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res., 57: 18411845, 1997. Fan, J., and Bertino, J. R. Modulation of cisplatinum cytotoxicity by p53: effect of p53-mediated apoptosis and DNA repair. Mol. Pharmacol., 56: 966 972, Fan, S., Smith, M. L., Rivet, D. J. I., Duba, D., Zhan, Q., Kohn, K. W., Fornace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649 1654, Hawkins, D. S., Demers, G. W., and Galloway, D. A. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res., 56: 892 898, Vikhanskaya, F., Colella, G., Valenti, M., Parodi, S., D'Incalci, M., and Broggini, M. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage. Clin. Cancer Res., 5: 937941, 1999. Pestell, K. E., Hobbs, S. M., Titley, J. C., Kelland, L. R., and Walton, M. I. Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Mol. Pharmacol., 57: 503511, 2000. Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C. X., Hanawalt, P. C., and Fornace, A. J., Jr. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and or gadd45 genes. Mol. Cell. Biol., 20: 37053714, 2000. Fan, S., Chang, J. K., Smith, M. L., Duba, D., Fornace, A. J., Jr., and O'Connor, P. M. Cells lacking CIP WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene, 14: 21272136, 1997. Jaffrezou, J. P., Chen, G., Duran, G. E., Kuhl, J. S., and Sikic, B. I. Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. J. Natl. Cancer Inst. Bethesda ; , 68: 11521158, 1994. Benedetti, P., Fiorani, P., Capuani, L., and Wang, J. C. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res., 53: 4343 4348, Owens, J. K., Shewach, D. S., Ullman, B., and Mitchell, B. S. Resistance to 1 D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutation with the deoxycytidine kinase gene. Cancer Res., 52: 2389 2393, Dumontet, C., Duran, G. E., Steger, K. A., Beketic-Oreskovic, L., and Sikic, B. I. Resistance mechanism in human sarcoma mutants derived by single-step exposure to paclitaxel Taxol ; . Cancer Res., 56: 10911097, 1996. Liu, P. K., Kraus, E., Wu, T. A., Strong, L. C., and Tainsky, M. A. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Oncogene, 12: 22672278, 1996. Smith, C. A., Baeten, J., and Taylor, J. S. The ability of a variety of polymerases to synthesize past site-specific cis-syn, trans-syn-II, 6 4 ; , and Dewar photoproducts of thymidylyl- 3 - 5 ; -thymidine. J. Biol. Chem., 273: 2193321940, 1998. Eckert, K. A., and Opresko, P. L. DNA polymerase mutagenic bypass and proofreading of endogenous DNA lesions. Mutat. Res., 424: 221236, 1999. McGregor, W. G. DNA repair, DNA replication, and UV mutagenesis. J. Investig. Dermatol., 4: 15, 1999. Vaisman, A., Varchenko, M., Umar, A., Kunkel, T. A., Risinger, J. I., Barrett, J. C., Hamilton, T. C., and Chaney, S. G. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinumDNA adducts. Cancer Res., 58: 3579 3585, Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Freidberg, E. C., Evans, M. K., and Taffe, B. G. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188 195, Therrien, J-P., Drouin, R., Baril, C., and Drobetsky, E. A. Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair. Proc. Natl. Acad. Sci. USA, 96: 15038 15043, Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature Lond. ; , 404: 42 49, Damia, G., Guidi, G., and D'Incalci, M. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur. J. Cancer, 34: 17831788, 1998.
Reporting medication errors was endorsed, along with the establishment of a culture conducive to rectifying processes that contribute to errors. Recommendations for Dispensing - : NCC MERP council council1999-03-19 Patient harm is more likely to occur when there are no mechanisms in place to prevent medication errors from reaching patients. For example, poor environmental conditions, distractions, and excessive workload all act to undermine safe medication use practices. The Council believed that one of its roles was to make recommendations that were easily adoptable by all health care professionals to protect patients. Thus, in March 1999, the Council adopted recommendations aimed at preventing errors that occur during the dispensing phase of the medication use process. Emphasis was placed on checking and rechecking labels, arranging product inventory to visually differentiate medications, designing dispensing areas that are conducive to uninterrupted work, and encouraging pharmacists to take an active role in counseling patients. Recommendations for Administration - : NCC MERP council council1999-0629 The Council also wanted to ensure that health care professionals who administer medications are knowledgeable about the drugs they administer and have easily-accessible product information. In June 1999, the Council adopted recommendations to reduce errors related to the administration of drugs in all areas of health care delivery, once again focusing on the five patient rights. Labels were to be checked three times and patients were to be continuously monitored for desired or adverse effects. The use of linked automated systems i.e., direct order entry, computerized medication administration records, and bar coding ; was encouraged to facilitate review of prescriptions, increase the accuracy of administration, and reduce transcription errors. The Council also recommended that data from actual or potential administration errors be continuously collected for quality improvement. Recommendations for Verbal Orders - : NCC MERP council council2001-0220 In 2001, the Council developed recommendations to reduce medication errors associated with verbal medication orders and prescriptions. Errors resulting from verbal orders are an area of particular concern because confusion over similar drug names or other aspects of the medication.
An air oxygen gas diffusion electrode for use as a cathode to replace the traditional hydrogen-evolving electrode in chlor-alkali electrolysis was assessed. Attempts to stabilize the cathode have been addressed in order to circumscribe problems associated with "flooding" or "wetting-in" properties. Variation of the hydrophobic concentration in the gas diffusion layer had a significant effect on the electrochemical tests of both the half-cell and electrolysis of the chlor-alkali cells. Life-tests as well as performance characteristics for both types of cells have shown encouraging results at NaOH concentration levels of ca 8M NaOH and temperatures of 70 and ca. 80 oC, respectively. Though cell voltages of about 2V were achieved and thereby reducing the energy consumption by 30-35% compared to the state-of-the-art membrane cell, the contributions of overvoltages were still high compared to the equilibrium potential of about 1.23V. Efforts to limit the individual parts of overvoltages as well as maintenance of the zero-gap cell at least on the anode side have been carried out. Two different kinds of cation exchange membranes have been used for the electrolysis cell. However, the cation exchange membrane with hydrophilic properties having high initial performances showed tendencies of blister formations.
Also inhibit tubulin polymerization but their binding to tubulin occurs at a different site from that of the Vinca alkaloids 28 ; . Taxol binds preferentially to microtubules, promotes their as sembly, and stabilizes them in vitro 29 ; . Taxotere mechanism of action is similar to that of taxol; in vitro, it inhibits cell replication, promotes the assembly of microtubules, and in duces the formation of microtubule bundles 27 ; . The concen tration required to provide 50% inhibition of microtubule dis assembly was found to be approximately 2 times less for Tax otere than for taxol 10 ; . The difference between the mechanism of action of Vinca alkaloids and Taxotere is also observed when comparing their in vivo spectrum of antitumor activity Table 9 ; 30 ; . Vincristine is mostly active against leukemias and has a limited solid tumor activity spectrum, with no activity against B16 melanoma and Glasgow osteogenic sarcoma, and only marginal activity against colon adenocarcinomas 38 and 51. Taxotere has a greater spectrum of activity than vincristine, and can achieve regression of advanced stage disease. We investigated Taxotere activity against CisDDP-sensitive and -insensitive tumors, because of an earlier clinical report showing taxol antitumor efficacy in ovarian carcinomas 3133 ; , some of which clearly refractory to CisDDP a reference drug for this disease ; . Our results indicated that Taxotere was active against both CisDDP-sensitive C51, COS, Lewis lung ; and CisDDP-refractory tumors advanced stage P03 and C38 ; . But Taxotere was also inactive on a CisDDP-sensitive tumor M5076 ; and on a tumor with acquired resistance to CisDDP L1210 CisDDP ; . Therefore we cannot generalize on Taxotere activity on CisDDP-sensitive and CisDDP-insensitive tumors. These results underline the well-known fact that each independ ently arising tumor is a unique biological entity with its own pattern of chemosensitivity 34 ; . In conclusion, Taxotere, obtained through the development of an efficient semisynthesis process using a renewable source of natural precursor, represents a truly new chemical entity with a unique mechanism of action, and a broad spectrum of antitumor activity different from that of other clinically avail able spindle poisons. This agent is currently undergoing Phase I clinical trials in Europe and in the United States of America.
Ko Shing Street, Hong Kong. It's a blazing morning in early September, with temperature and humidity both in the 90s. "Take lots of water, " our friend Iris warned us before we descended from her air-conditioned haven on the twenty-eighth floor. We'd spent the night before in her glass-walled guest room, and could hardly bear to sleep, the view was so enchanting, through the neon skyscrapers that parade down the steep slope to the harbor, out over the procession of freighters and junks and hydrofoils skimming the dim sheet of water, across to glittering Kowloon and beyond to the mountainous bulk of the Chinese mainland. Seen from above, Hong Kong is gleaming and futuristic, a cool, high-tech, glass-and-steel machine. But at street level, it's another matter entirely, steamy and seething with humanity. Just as was true many dynasties ago in China, each neighborhood and every street has its own trade, and in Ko Shing Street, a stone's throw from the world's second-tallest building, it is traditional medicines. A weird, chokingly sweet smell pours from the open fronts of the shops. Dried lizards are mounded next to heaps of huge, shiny tree fungus, chrysanthemum blossoms pressed into ruffled cakes, bundles of powdery sticks, and rows of earthenware jars crosshatched with Chinese characters and taxotere.
Minute urination volume in the mouse. Most notably, age-dependent increases in voided volume starting from a weaning period are reported for the first time in normal mice. This method will be a powerful tool for evaluating mouse models of lower urinary tract dysfunction.
Polymerization of microtubules with Taxol paclitaxel, Sigma, St. Louis, MO ; was performed by the stepwise addition of Taxol [ : mitchison.med. harvard protocols poly ]. Taxol microtubules were frozen in small aliquots at 80C. GMPCPP microtubules were prepared by three cycles of polymerization in the presence of 50 M GMPCPP purchased from Jena Biosciences, Jena, Germany ; without any additional GTP or GDP, and they were prepared fresh from P11 tubulin for each experiment and tazorac.
Fig. 3. Effect of paclitaxel A ; and CD437 B ; on the growth of 2008, 13 and 2008 17 4 cells. The 2008 F ; , 2008 13 4 E ; , and 200817 4 cells OE ; were treated with various concentrations of Taxol A ; and CD437 B ; , and after 72 h, growth was assessed by MTT assay 6 ; . Values, means SD of triplicate samples from three individual experiments.
Figs. 14 to 19. Transmission electron micrographs of Type III and IV prokaryotes from deparaffinized Dreissena sp. digestive tissues re-embedded in resin. RER: rough endoplasmic reticulum; N: nucleus; R: ribosomes; SC: secretory cell; DC: digestive cell. Fig. 14. Intracytoplasmic inclusion body containing irregularly rounded prokaryote organisms typical of Type III found in a secretory cell of a digestive gland tubule. Fig. 15. Higher magnification of large prokaryote cells of Type III; the cytoplasm of Type III prokaryotes contains ribosomes and electron-lucent patches corresponding to DNA strands arrows ; . Fig. 16. Intracytoplasmic inclusion body containing large rounded prokaryote organisms typical of Type IV found in a secretory cell of a digestive gland tubule. Fig. 17. Details of large Type IV prokaryote cells containing virus-like particles occasionally occurring in paracrystalline array arrowheads ; . Fig. 18. Higher magnification of hexagonal virus-like particles in paracrystalline array each with a clear central zone occurring in the cytoplasm of Type IV prokaryote cells. Fig. 19. High magnification of the peripheral zone of an inclusion containing Type IV prokaryote cells arrowhead ; and their virus-like particles; note the single tubule of rough endoplasmic reticulum in the cytoplasm of this digestive cell and that no membrane apparently separates it from the prokaryote cells and telithromycin.
Acid 6.2 mg, 0.036 mmol ; , MeOH 22 L, 0.9 mmol ; and toluene 15 mL ; . The mixture was stirred at 100oC for 2 h under 10 atm of carbon monoxide. After cooling and releasing the excess carbon monoxide, the reaction mixture was filtered over Celite and the solvent was evaporated under reduced pressure. Methyl - 3-benzoylphenyl ; acrylate 9 ; was obtained in 93% GC yield and 97% regioselectivity [GC-MS EI, 70 eV ; 266 M + , 28% ; , 206 15% ; , 189 57% ; , 105 100% ; , 102 13% ; , 101 13% ; , 77 79% ; . After concentration, a 2 mol L-1 KOH aqueous solution 0.6 mL ; and acetone 5 mL ; were added to the ester 9 and the mixture was stirred at room temperature for 16 h. The aqueous solution was washed with ether 20 mL ; and acidified with concentrated HCl to pH 1. The organic acid was extracted with ether 3 x 30 washed with saturated aqueous NaCl 3x 30 mL ; and dried with anhydrous Na2SO4. Evaporation under vacuum gave - 3-benzoylphenyl ; acrylic acid35 159 mg, 82% ; . 1H NMR 200 MHz, CDCl3, ; : 6.10 s, 1H ; , 6.61 s, 1H ; , 7.29-8.00 m, 9H ; , 9.40 br, 1H ; . Hydrogenation of- 3-benzoylphenyl ; acrylic acid 6 ; In a 100 mL-stainless steel autoclave under argon were placed 6 59 mg, 0.23 mmol ; , [RuCl2- S ; -BINAP]2.Et3N 5.4 mg, 0.0032 mmol ; and methanol 15 mL ; . The reactor was pressurized with hydrogen 25 atm ; and stirred at room temperature for 22 h. After releasing the excess hydrogen, the reaction mixture was filtered over Celite and the solvent was evaporated under reduced pressure. The residue was then acidified with 10% HCl and extracted with ether 3 x 20mL ; . The ethereal extract was washed with brine 20 mL ; and dried over anhydrous MgSO4. The solvent was evaporated under reduced pressure giving 53 mg of a mixture of 1 91% ; and 6 9% ; . The optical rotation observed showed an excess of the S ; -Ketoprofen enantiomer. The mixture of hydrogenated and unhydrogenated acids was transformed into their methyl esters . An enantiomeric excess of 43% was determined on a Varian-CX-3400 GC equipped with a chiral column CP-Chirasil-Dex CB 25m x 0, 25 mm mmm P H2 20 psi ; oven temperature 150 isotherm methyl ester of S ; -ketoprofen 49.4 min and methyl ester of R ; -ketoprofen 50.8 min.
FIG. 4. Immunofluorescence of VSV-G in BAECs infected with ts045 in the absence A ; or presence B-D ; of 4 taxol. Cells were fixed 15 min after release of the temperature block in transport. Taxol 4 ; treatment was 60 min at 37C prior to ts045 infection and temodar.
Figure 4.30. Rituximab sales per individual dying of NHL in the Czech Republic, Hungary and Poland number of deaths by year 2000 ; . Year 01 Q1 represents the time of introduction and or first sales in each respective country. Source IMS Health, IMS MIDAS Quantum Q4 2004. As shown in Figure 4.28, Austria, Spain and Switzerland are leaders in the uptake of rituximab. Most other countries tend to be just below or close to the European average.
HOMEOPATHIC SOLUTIONS: It's important to do some reading about homeopathics if you are new to the subject. It's a very different discipline than other methods. You will need to take the remedy only in a clean mouth nothing to eat or drink for 15 min. either side of the remedy, and avoid things that could antidote your remedy: like coffee in any form ; , mint toothpaste, gum, tea ; , camphor Tiger Balm, Chapstick, Vapo-Rub ; . The ideal way to be treated Homeopathically is to go Homeopathic Practitioner. See if you can find one near to you. There has never been an allergic reaction or a negative side effect from a Homeopathic remedy in the over 200 years of use. This makes it ideal for pregnancy & children. The common first-aid type remedies can be safely used by anyone, at any time. These are in both 10 X & 30X potency together ; : ARNICA: amazing stuff for any tissue traumas; bruising, swelling injuries--due to giving birth, or otherwise. Use as often as needed. If you have an injury you may want to use both the solution internally, and the oil externally oil not on broken skin ; ACONITE: used especially for situations of emotional upset or fear, panic; fear of tests, also symptoms of sudden onset, like sudden earache or cough. APIS: for bee or insect stings, and hives please be aware that medical emergencies need to be treated medically, but you could use this on the way to that care, and often reduce the immediate discomforts ; CARBO. VEG: to reduce exhaustion, both mental , emotional & physical LEDUM: for the itching from bug bites, also to help puncture wounds to heal well KALI. BICHROM.: usually helps sinus trouble within minutes KALI. MUR.: usually helps stuffy nasal congestion situations quickly RHUS TOX.: used for poison ivy & oak, can help to heal it up. My sons would use it if they were going to be exposed to P.I., to keep from getting it take a few drops 2 times a day for this reason ; SINUS MIX: this is a combination remedy for sinus trouble, it has: Kali Bi., Kali Mur., Pulsatilla, Balladonna., & Nux Vom. in a 10 and 30X potency. Helps a lot of folks with sinus trouble, without the side effects of the "regular" drugs. This is our second most popular Homeopathic remedy. SURGICAL REPAIR MIX: this is another combination remedy that I started making for myself & friends that wanted something to help after surgery or birth ; that would be drug-free. It has Arnica for tissue damage ; , Hypericum for pain ; , Symphytum for soft tissue repair ; & Staphysagria for physical & emotional help after surgery ; . People really like the way it works. Repeat as needed, for relief, and to assist the healing of tissues. This is our most popular Homeopathic remedy. Dosages: usually most people find that 2 drops taken under the tongue ; when the symptoms present works the best for them. You should read books on homeopathy to find out all the details. You can request a one page handout that I have written, which has most of the most basic ideas on it if you are interested, send either a SASE, or include a request with your order. The Homeopathic solutions are approximately 30% alcohol by volume. MORE THAN 200 OTHER REMEDIES AVAILABLE UPON REQUEST . Check your local health food store as Homeopathic remedies are out there everywhere now and tenex.
Taxol overdose
In this issue Contents of the next issue 611 News Award lectures at ECCO-6, Florence EEC directive a threat to scientific meetings? Fight on Taxol heats up FDA gets tough with drug manufacturers Drug marketing in Europe: Confusion ahead? At last, some exciting new drugs Quality control in the EORTC: Little money, numerous tasks ESMO pressures FECS Perhaps not everyone knows that 612 Editorials Early bone marrow transplantation for patients with potentially curable malignancies J.O.Armitage How should prognostic factors influence therapy in follicular lymphomas? B. Coiffier Clinical research in advanced breast cancen Back to the future?.
To cell cycle arrest. Possible mechanisms of Taxol-induced apoptosis have been proposed 52 ; . In A549 cells, it has been proposed that Taxol-mediated cell death may result from two different mechanisms; at low Taxol concentrations 9 nM ; , cell death may occur without a G2-M block, whereas at higher concentrations 9 nM ; , cell death may result from terminal mitotic arrest 24 ; . In this study, we demonstrated that Taxol, at concentrations 10 20 nM, induced p66shc serine phosphorylation that coincided with Taxol-induced activation of Raf-1 and ERK1 2 and with Taxol-induced release of PARP cleavage products, an early event in apoptosis. Two lines of evidence suggest that Taxol-mediated serine phosphorylation of p66shc is related to the blockade of cells in mitosis: a ; the gel mobility shift of p66shc is induced not only by Taxol but also by other microtubuleinteracting agents, all of which are antimitotic drugs; and b ; the maximum effect of the electrophoretic mobility shift of p66shc was seen at 9 18 after Taxol treatment, a time at which a high proportion of the cells would be in mitosis see Fig. 3 ; . The recent finding that disruption of p66shc function, by mutating the serine phosphorylation site, enhances cellular resistance to apoptosis 39 ; suggests that the phosphorylation of p66shc reported here may modulate Taxolinduced apoptosis. In a classical Ras-dependent signal transduction pathway that leads to the activation of ERK1 2, tyrosine phosphorylation of Shc results in Shc Grb2 SOS ternary complex formation and the subsequent activation of Ras and Raf-1. In Taxol-treated A549 cells, although a Taxolinduced Raf-1 mobility shift coincides with phosphorylation of p66shc, Raf-1 phosphorylation may not be the downstream event of p66shc phosphorylation. Rather, both of these events may be the consequence of mitotic arrest resulting from the action of antimitotic agents. The emergence of drug resistance is a significant clinical problem that develops during the treatment of most human malignancies with antitumor agents, including Taxol. Potential mechanisms involved in Taxol resistance include overexpression of P-glycoprotein 53 ; , mutations in tubulin that may influence its interaction with Taxol 54 ; , and overexpression of c-erbB-2 neu in breast cancer cells 55 ; . In Taxol-resistant A549-T12 cells that do not express P-glycoprotein, both the phosphorylation of p66shc and Raf-1 induced by Taxol were diminished, compared with drug-sensitive cells. The report that p66shc knockout mice have an increased resistance to oxidative stress and a longer life span 39 ; agrees with the results obtained with A549-T12 cells that are resistant to Taxol and whose p66shc is not activated by 20 nM Taxol. In summary, we have identified a Taxol-mediated signaling event that is distinct from those effects elicited by micromolar concentrations of Taxol in mouse macrophages. It is also different from mitogen-activated processes, in which both tyrosine and serine threonine phosphorylation of Shc proteins occurs rapidly. It is known that serine phosphorylation occurs during mitosis 56 ; , and it is probable that serine kinases are up-regulated or activated at this phase of the cell cycle. The altered serine phosphorylation of p66shc that occurs in the presence of a variety of molecules that interact with the tubulin microtubule system may relate to the dramatically prolonged and abnormal time that such cells are in the mitotic phase of the cell cycle. ACKNOWLEDGMENTS and teniposide.
Discount Drugs
330. RECURRE NT GLIOBLA STOMA RGBM ; TREATED WITH FRACTIONATED STEREOTACTIC RADIOSURGERY AND TAXOL FSR T ; Lederman, G. 1 , Arbit, E. 2 , Pannullo, S. 2 , Lowry, J.3 , Wertheim, S. 3 , Fine, M. 3 , Raden, M. 3 , Silverman, P.1 , Grosman, I. 1 , Bockowski, D. 1 ; 1 Dept. of Radiation Oncology, 2 Dept. of Neurosurgical Oncology, Dept. of Radiology, Staten Island University Hospital, New York, USA Background: Radiosurgery in divided doses administered concurrently with a radiosensitizer, Taxol, offers the appeal of hypo-fractionated therapy utilizing a relocatable Gil-Thomas-Cosman head frame. FSR T was compared in patient sub-groups, all of whom had RGBM. Materials and Methods: Overall 128 patients pts ; aged 14 to 81 years mean 55 ; with a tumor volume of 0.05 to 176.0cc median 25.3 ; , receiving a dose of 300 to 900 Centigray cGy ; median 600 ; in 4 or fractions with Karnofsky KPS ; scores of 30 to 100 median 70 ; were treated and followed 1 to 33 mos median 5 ; . Weekly Taxol dose ranged from 80 to 180mg m 2 median 120mg m 2 ; Pts were analyzed in groups by tumor volume. Results: 56 pts with volume 30cc or less aged 26 to 81 years mean 57 ; with median KPS 70, had 86 tumors ranging in volume from 0.05 to 29.3cc median 7.4 ; receiving a median dose 600cGy in 4 or fractions. Clinical follow-up ranged from 1 to 33 mos median 6 ; , with 12 mos survival 39% and 7% at 24 mos from time of treatment median 9.4 ; . Survival from diagnosis is 73% at 12 mos and 23% at 24 mos median 16.0 ; . 72 pts with tumors greater than 30cc aged 14 to 79 years mean 52 ; with median KPS 65, had 74 tumors ranging in volume from 30.9 to 176.0cc median 43.9 ; receiving a median dose 600cGy in 4 or fractions followed 1 to 19 mos median 4 ; . Survival from treatment is 12% at 12 mos median 6.7 ; . 12 mos survival from diagnosis is 71% at 12 mos and 14% at 24 mos median 14.7 ; . Conclusion: This data would suggest that pts with large and small RGBM have a substantial prospective of surviving 12 months after FSR T regardless of tumor volume. Therefore, FSR T offers the chance of prolonged survival with a minimum of side effects, especially for pts with volume 30cc or less and taxol.
COMMISSION ACCOMPLISHMENTS The Commission reviewed nineteen 19 ; complaints between patients and facilities. Additionally, the Commission surveyed seventy-nine 79 ; facilities for compliance with standards of care, and addressed all corrective action plans that emerged from such surveys. The Office of Health Care Quality is mandated by law to survey 33 % of existing facilities on an annual basis. The Commission's policy is to survey and certify the remaining 60% 70% of the facilities, ensuring that 100% of the dialysis and transplant facilities in the State are surveyed on an annual basis. In calendar year 2005 the Commission surveyed 79 dialysis facilities. Through the corrective action plan process all Federal and State regulations were enforced by the Commission. Through this process, the Commission has met its mandate, to enforce compliance with State, Federal and Commission regulations, thus enhancing the quality of care rendered to the ESRD population in the state of Maryland. The Commission continues to work with the Office of Healthcare Quality OHCQ ; to foster communication between the two offices. Presently, a wonderful cooperation between the Commission and OHCQ enables both entities timely responses to complaints, and therefore patients' welfare and safety is addressed through immediate intervention. The Commission completed and mailed a newsletter to the renal community. The newsletter is a tool to inform the community about the Commission's activities, and to provide educational information. Upon request by the Renal Social Workers in Maryland, the Commission is working with this group to address their responsibilities and changing roles in the dialysis facilities. Subsequently, a subcommittee was formed, protocols were developed, facilities were surveyed and Social Work Guidelines were developed and distributed to the social workers in the Renal Community. The Commission has promulgated these guidelines into regulations. The Commission meetings are forums to inform and educate the renal community. Therefore, all Open Session minutes are distributed to the renal community and all dialysis facilities and their staff. The Commission addressed ongoing issues surrounding dialysis facility discharge practices and continuity of care issues. The Commission through the survey process is working with facilities to ensure their compliance with the Mid-Atlantic Renal Coalition's transplant objectives. Transplant subcommittee was formed to determine elements for the surveyor to investigate during transplant surveys, work on issues between the transplant centers and dialysis facilities and to determine grievance channels for patients with transplant issues and tenofovir.
Naturally occurring taxol is derived from the bark of the pacific yew tree taxus brevifolia ; , but yield is extremely low.
| Generic TaxolOTHER 190. Trends in ophthalmology job availability in the NHS over the past 4 years D R Anijeet, R J Hanson Ninewells University Hospital 191. The Fabry Outcome Survey: A comprehensive approach for documenting the ocular manifestations in Anderson Fabry Disease A Ioannidis, K Dasingani, A Sodi, S Pitz, D Hughes, A Mehta, C Davey Royal Free Hospital NHS Trust 192. A Save Your Sight Campaign Leaflet: can people accurately self assess their vision? J Purdell-Lewis, R P Gale, L Brooles, A Douglas, A Cassels-Brown The Leeds Teaching Hospitals NHS Trust 193. Radio-imaging in Ophthalmology: Are we over-investigating? R Arora, T Criddle, K Sahni, J Shankar, N Kaushik Wrexham Maelor Hospital, Wrexham 194. Attitudes of newly appointed consultants to mentoring- What support, for further learning, do newly appointed consultants need? S Winder Sheffield Teaching Hospitals 195. Custom designed conformer plaque radiotherapy for conjunctival malignancy M S Sagoo, C L Shields, A Mashayekhi, J Emrich, J Freire, J A Shields Wills Eye Hospital, Philadelphia, USA 196. Referral patterns to low vision support services RJ Barry, S R Mukanganwa, P I Murray, S Rauz Birmingham and Midland Eye Centre 197. Assessment of applications received for the post of SHO-Ophthalmology at District General Hospital in UK V Sharma, B Gupta, S Sharma, T Soong, N O'Donnell Southport General Infirmary 198. Assessment of contrast sensitivity measurement with SIFIMAVcomputerised vision analysis system S Singaram, M Leyland West Berkshire Community Hospital, Newbury 199. Eyes and Vision Specialist Library : National Knowledge Weeks S Burman-Roy, J Wood, R Seeberan, P Desai Moorfields Eye Hospital and tequin.
Cheap Taxol online
Taxoll, haxol, taxok, txaol, tadol, 5axol, tazol, 6axol, yaxol, gaxol, tax0l, taxxol, taxo, taxoo, axol, tsxol, taaxol, taxpl, taol.
|
| |
|